Calls For Medical Paper Retractions Prompt NIH To Pause Experimental Stem Cell Treatment Trial
Fallout from questions raised about the research and journal publications from the lab of Dr. Piero Anversa, a controversial stem cell researcher, leads a federal agency to temporarily halt a clinical trial studying a stem cell therapy for heart failure patients. And The New York Times reports more on Anversa's troubles.